Design, synthesis, and evaluation of multitarget-directed ligands against Alzheimer’s disease based on the fusion of donepezil and curcumin

A new and rapid colorimetric determination of acetylcholinesterase activity

Ellman, G. L., Courtney, K. D., Andres, V., & Featherstone, R. M. (1961) · Biochemical Pharmacology · doi:10.1016/0006-2952(61)90145-9 · Cited by 27,221 · see citing works

Development and Validation of an Improved Oxygen Radical Absorbance Capacity Assay Using Fluorescein as the Fluorescent Probe

Ou, B., Hampsch‐Woodill, M., & Prior, R. L. (2001) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf010586o · Cited by 2,936 · see citing works

The evolving role of natural products in drug discovery

Koehn, F. E., & Carter, G. T. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1657 · Cited by 2,579 · see citing works

Curcumin Inhibits Formation of Amyloid β Oligomers and Fibrils, Binds Plaques, and Reduces Amyloid in Vivo

Yang, F., Lim, G. P., Begum, A. N., Ubeda, O. J., Simmons, M. R., Ambegaokar, S. S., Chen, P. P., Kayed, R., Glabe, C. G., Frautschy, S. A., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m404751200 · Cited by 2,336 · see citing works

High throughput artificial membrane permeability assay for blood–brain barrier

Di, L., Kerns, E. H., Fan, K., McConnell, O. J., & Carter, G. T. (2003) · European Journal of Medicinal Chemistry · doi:10.1016/s0223-5234(03)00012-6 · Cited by 1,195 · see citing works

Neurobiology of butyrylcholinesterase

Darvesh, S., Hopkins, D. A., & Geula, C. (2003) · Nature reviews. Neuroscience · doi:10.1038/nrn1035 · Cited by 896 · see citing works

Treatment of Alzheimer's disease; current status and new perspectives

Scarpini, E. A., Scheltens, P., & Feldman, H. (2003) · The Lancet Neurology · doi:10.1016/s1474-4422(03)00502-7 · Cited by 720 · see citing works

Metals in Alzheimer's and Parkinson's Diseases

Barnham, K. J., & Bush, A. I. (2008) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2008.02.019 · Cited by 695 · see citing works

Modern Natural Products Drug Discovery and Its Relevance to Biodiversity Conservation

Kingston, D. G. I. (2010) · Journal of Natural Products · doi:10.1021/np100550t · Cited by 521 · see citing works

Donepezil Hydrochloride (E2020) and Other Acetylcholinesterase Inhibitors

Sugimoto, H., Yamanish, Y., Iimura, Y., & Kawakami, Y. (2000) · Current Medicinal Chemistry · doi:10.2174/0929867003375191 · Cited by 328 · see citing works

Biological metals and Alzheimer's disease: Implications for therapeutics and diagnostics

Duce, J. A., & Bush, A. I. (2010) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2010.04.003 · Cited by 281 · see citing works

Design, Synthesis, and Evaluation of Multitarget-Directed Resveratrol Derivatives for the Treatment of Alzheimer’s Disease

Lu, C., Guo, Y., Yan, J., Luo, Z., Luo, H., Yan, M., Huang, L., & Li, X. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm400567s · Cited by 230 · see citing works

Inhibition of Acetylcholinesterase, β-Amyloid Aggregation, and NMDA Receptors in Alzheimer’s Disease: A Promising Direction for the Multi-target-Directed Ligands Gold Rush

Rosini, M., Simoni, E., Bartolini, M., Cavalli, A., Ceccarini, L., Pascu, N., McClymont, D. W., Tarozzi, A., Bolognesi, M. L., Minarini, A., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm800577j · Cited by 186 · see citing works

Synthesis and Evaluation of Multi-Target-Directed Ligands against Alzheimer’s Disease Based on the Fusion of Donepezil and Ebselen

Luo, Z., Sheng, J., Sun, Y., Lu, C., Yan, J., Liu, A., Luo, H., Huang, L., & Li, X. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm401047q · Cited by 178 · see citing works

Multitarget-Directed Benzylideneindanone Derivatives: Anti-β-Amyloid (Aβ) Aggregation, Antioxidant, Metal Chelation, and Monoamine Oxidase B (MAO-B) Inhibition Properties against Alzheimer’s Disease

Huang, L., Lu, C., Sun, Y., Mao, F., Luo, Z., Su, T., Jiang, H., Shan, W., & Li, X. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300978h · Cited by 153 · see citing works

Design, Synthesis, and Evaluation of Orally Available Clioquinol-Moracin M Hybrids as Multitarget-Directed Ligands for Cognitive Improvement in a Rat Model of Neurodegeneration in Alzheimer’s Disease

Wang, Z., Wang, Y., Wang, B., Li, W., Huang, L., & Li, X. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01222 · Cited by 120 · see citing works

Homobivalent Quinazolinimines as Novel Nanomolar Inhibitors of Cholinesterases with Dirigible Selectivity toward Butyrylcholinesterase

Decker, M. W. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm060682m · Cited by 101 · see citing works

Acetylcholine: Future research and perspectives

van der Zee, E. A., Platt, B., & Riedel, G. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2011.01.050 · Cited by 59 · see citing works

A new route to 2-alkenyl-1,3-dicarbonyl compounds, intermediates in the synthesis of dihydrofurans

Antonioletti, R., Bovicelli, P., & Malancona, S. (2002) · Tetrahedron · doi:10.1016/s0040-4020(01)01173-5 · Cited by 56 · see citing works

Donepezil: a clinical review of current and emerging indications

Román, G. C., & Rogers, S. (2004) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.5.1.161 · Cited by 55 · see citing works

Oxygen radical absorbance capacity (ORAC) of cyclodextrin-solubilized flavonoids, resveratrol and astaxanthin as measured with the ORAC-EPR method

Sueishi, Y., Ishikawa, M., Yoshioka, D., Endoh, N., Oowada, S., Shimmei, M., Fujii, H. G., & Kotake, Y. (2011) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.11-21 · Cited by 49 · see citing works

Reducing Aβ load and tau phosphorylation: Emerging perspective for treating Alzheimer's disease

Kalra, J., & Khan, A. G. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.07.043 · Cited by 47 · see citing works

Auguste D. and Alzheimer's Disease

O’Brien, C. (1996) · Science · doi:10.1126/science.273.5271.28 · Cited by 42 · see citing works

Nicotinic ligands as multifunctional agents for the treatment of neuropsychiatric disorders

Terry, A. V., Callahan, P. M., & Hernandez, C. M. (2015) · Biochemical Pharmacology · doi:10.1016/j.bcp.2015.07.027 · Cited by 40 · see citing works

Amyloid-β-Induced Amyloid-β Secretion: A Possible Feed-Forward Mechanism in Alzheimer's Disease

Marsden, I. T., Minamide, L. S., & Bamburg, J. R. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-101899 · Cited by 35 · see citing works

Exploring the Structure−Activity Relationships of [1-(4-tert-Butyl-3‘-hydroxy)benzhydryl-4-benzylpiperazine] (SL-3111), A High-Affinity and Selective δ-Opioid Receptor Nonpeptide Agonist Ligand

Alfaro-Lopez, J., Okayama, T., Hosohata, K., Davis, P., Porreca, F., Yamamura, H. I., & Hruby, V. J. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm990337f · Cited by 26 · see citing works

Facile and Straightforward Method Leading to Substituted 4-Amino-1-arylpyrazoles

Šimůnek, P., Svobodova, M., Bertolasi, V., & Macháček, V. (2008) · Synthesis · doi:10.1055/s-2008-1067042 · Cited by 16 · see citing works

Development of Multifunctional Molecules as Potential Therapeutic Candidates for Alzheimer’s Disease, Parkinson’s Disease, and Amyotrophic Lateral Sclerosis in the Last Decade

Savelieff, M. G., Nam, G., Kang, J., Lee, H. J., Lee, M., & Lim, M. H. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00138 · Cited by 603 · see citing works

Protective Effects of Indian Spice Curcumin Against Amyloid-β in Alzheimer’s Disease

Reddy, P. H., Manczak, M., Yin, X., Grady, M. C., Mitchell, A., Tonk, S., Kuruva, C. S., Bhatti, J. S., Kandimalla, R., Vijayan, M., et al. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-170512 · Cited by 354 · see citing works

Multi-target design strategies for the improved treatment of Alzheimer's disease

Zhang, P., Xu, S., Zhu, Z., & Xu, J. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.05.020 · Cited by 218 · see citing works

Multifactorial Hypothesis and Multi-Targets for Alzheimer’s Disease

Gong, C., Liu, F., & Iqbal, K. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-179921 · Cited by 184 · see citing works

Polyphenols as Potential Metal Chelation Compounds Against Alzheimer’s Disease

Lakey‐Beitia, J., Burillo, A., Penna, G. L., Hegde, M. L., & Rao, K. S. J. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200185 · Cited by 190 · see citing works

Curcumin analogues and their hybrid molecules as multifunctional drugs

Noureddin, S. A., El‐Shishtawy, R. M., & Alfooty, K. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.111631 · Cited by 158 · see citing works

Curcumin in Health and Diseases: Alzheimer’s Disease and Curcumin Analogues, Derivatives, and Hybrids

Chainoglou, E., & Hadjipavlou‐Litina, D. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21061975 · Cited by 161 · see citing works

Molecular Hybridization as a Tool in the Design of Multi-target Directed Drug Candidates for Neurodegenerative Diseases

Gontijo, V. S., Viegas, F. P. D., Ortiz, C. J. C., Silva, M. D. F., Damásio, C. M., Rosa, M. C., Campos, T. G., Couto, D. S., Dias, K. S. T., & Viegas, C. (2019) · Current Neuropharmacology · doi:10.2174/1385272823666191021124443 · Cited by 147 · see citing works

Ethnopharmacological Approaches for Dementia Therapy and Significance of Natural Products and Herbal Drugs

Tewari, D., Stankiewicz, A. M., Mocan, A., Sah, A. N., Tzvetkov, N. T., Huminiecki, Ł., Horbańczuk, J. O., & Atanasov, A. G. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00003 · Cited by 136 · see citing works

Traditional Chinese medicinal herbs as potential AChE inhibitors for anti-Alzheimer’s disease: A review

Jiang, Y., Gao, H., & Turdu, G. (2017) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2017.09.004 · Cited by 128 · see citing works

Curcumin in Alzheimer’s disease: Can we think to new strategies and perspectives for this molecule?

Serafini, M. M., Catanzaro, M., Rosini, M., Racchi, M., & Lanni, C. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.08.004 · Cited by 119 · see citing works

Curcumin and Its Derivatives as Theranostic Agents in Alzheimer’s Disease: The Implication of Nanotechnology

Shabbir, U., Rubab, M., Tyagi, A., & Oh, D. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms22010196 · Cited by 117 · see citing works

Indian Medicinal Herbs and Formulations for Alzheimer’s Disease, from Traditional Knowledge to Scientific Assessment

Mehla, J., Gupta, P., Pahuja, M., Diwan, D., & Diksha, D. (2020) · Brain Sciences · doi:10.3390/brainsci10120964 · Cited by 108 · see citing works

Novel small molecule therapeutic agents for Alzheimer disease: Focusing on BACE1 and multi-target directed ligands

Iraji, A., Khoshneviszadeh, M., Firuzi, O., Khoshneviszadeh, M., & Edraki, N. (2020) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2020.103649 · Cited by 102 · see citing works

Computational Studies Applied to Flavonoids against Alzheimer’s and Parkinson’s Diseases

Monteiro, A., Viana, J. D. O., Nayarisseri, A., Ernestine, N., Mendonça, F. J. B., Scotti, M. T., & Scotti, L. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/7912765 · Cited by 96 · see citing works

4,6-Diphenylpyrimidine Derivatives as Dual Inhibitors of Monoamine Oxidase and Acetylcholinesterase for the Treatment of Alzheimer’s Disease

Kumar, B., Dwivedi, A. R., Sarkar, B., Gupta, S. K., Krishnamurthy, S., Mantha, A. K., Parkash, J., & Kumar, V. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00220 · Cited by 92 · see citing works

Dipropargyl substituted diphenylpyrimidines as dual inhibitors of monoamine oxidase and acetylcholinesterase

Kumar, B., Kumar, V., Prashar, V., Saini, S., Dwivedi, A. R., Bajaj, B., Mehta, D., Parkash, J., & Kumar, V. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.05.039 · Cited by 91 · see citing works

Natural products and their derivatives as multifunctional ligands against Alzheimer's disease

Patil, P., Thakur, A., Sharma, A., & Flora, S. J. S. (2019) · Drug Development Research · doi:10.1002/ddr.21587 · Cited by 81 · see citing works

The chemistry toolbox of multitarget-directed ligands for Alzheimer's disease

Mesiti, F., Chavarria, D., Gaspar, A., Alcaro, S., & Borges, F. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.111572 · Cited by 74 · see citing works

Profiling donepezil template into multipotent hybrids with antioxidant properties

Mezeiová, E., Špilovská, K., Nepovimová, E., Górecki, L., Soukup, O., Doležal, R., Maliňák, D., Janočková, J., Jun, D., Kuča, K., et al. (2018) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2018.1443326 · Cited by 74 · see citing works

The recent development of donepezil structure-based hybrids as potential multifunctional anti-Alzheimer's agents: highlights from 2010 to 2020

Kareem, R. T., Abedinifar, F., Mahmood, E. A., Ebadi, A. G., Rajabi, F., & Vessally, E. (2021) · RSC Advances · doi:10.1039/d1ra03718h · Cited by 59 · see citing works

Multi-Target-Directed Ligands as an Effective Strategy for the Treatment of Alzheimer’s Disease

Kumar, R., Kumar, V., Kumar, B., Thakur, A., & Dwivedi, A. R. (2021) · Current Medicinal Chemistry · doi:10.2174/0929867328666210512005508 · Cited by 54 · see citing works

Perspectives for New and More Efficient Multifunctional Ligands for Alzheimer′s Disease Therapy

Zagórska, A., & Jaromin, A. (2020) · Molecules · doi:10.3390/molecules25153337 · Cited by 51 · see citing works

Role of nutraceuticals on neurodegenerative diseases: neuroprotective and immunomodulant activity

Fumia, A., Cicero, N., Gitto, M., Nicosia, N., & Alesci, A. (2021) · Natural Product Research · doi:10.1080/14786419.2021.2020265 · Cited by 49 · see citing works

Design, Synthesis, and Pharmacological Evaluation of N-Propargylated Diphenylpyrimidines as Multitarget Directed Ligands for the Treatment of Alzheimer’s Disease

Kumar, B., Dwivedi, A. R., Arora, T., Raj, K., Prashar, V., Kumar, V., Singh, S., Prakash, J., & Kumar, V. (2022) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.2c00132 · Cited by 47 · see citing works

Curcumin hybrid molecules for the treatment of Alzheimer's disease: Structure and pharmacological activities

Zang, W.-B., Wei, H., Zhang, W., Ma, W., Li, J., & Yao, Y. (2023) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2023.116070 · Cited by 44 · see citing works

Thermoresponsive in situ gel of curcumin loaded solid lipid nanoparticle: Design, optimization and in vitro characterization

Agrawal, M., Pradhan, M., Singhvi, G., Patel, R. J., Ajazuddin, M., & Alexander, A. (2022) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2022.103376 · Cited by 39 · see citing works

A Review on Recent Development of Novel Heterocycles as Acetylcholinesterase Inhibitor for the Treatment of Alzheimer’s Disease

Patel, A. D., Shah, D., Patel, Y., Patel, S. N., Mehta, M., & Bambharoliya, T. (2022) · Current Drug Targets · doi:10.2174/1389450124666221213114500 · Cited by 37 · see citing works

Donepezil: A review of the recent structural modifications and their impact on anti-Alzheimer activity

Mohsin, N. U. A., & Ahmad, M. (2020) · Brazilian Journal of Pharmaceutical Sciences · doi:10.1590/s2175-97902019000418325 · Cited by 39 · see citing works

Curcumin as Scaffold for Drug Discovery against Neurodegenerative Diseases

Cascio, F. L., Marzullo, P., Kayed, R., & Piccionello, A. P. (2021) · Biomedicines · doi:10.3390/biomedicines9020173 · Cited by 37 · see citing works

Inhibition of amyloid fibril formation and disassembly of pre-formed fibrils by natural polyphenol rottlerin

Šipošová, K., Kožár, T., Huntošová, V., Tomková, S., & Musatov, A. (2018) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2018.10.002 · Cited by 35 · see citing works

Biological evaluation and molecular docking of novel 1,3,4-thiadiazole-resorcinol conjugates as multifunctional cholinesterases inhibitors

Skrzypek, A., Matysiak, J., Karpińska, M. M., Czarnecka, K., Kręcisz, P., Stary, D., Kukułowicz, J., Paw, B., Bajda, M., Szymański, P., et al. (2021) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2020.104617 · Cited by 34 · see citing works

Curcumin derivatives and Aβ-fibrillar aggregates: An interactions’ study for diagnostic/therapeutic purposes in neurodegenerative diseases

Orteca, G., Tavanti, F., Bednáriková, Z., Gažová, Z., Rigillo, G., Imbriano, C., Basile, V., Asti, M., Rigamonti, L., Saladini, M., et al. (2018) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2018.07.027 · Cited by 33 · see citing works

Design, Synthesis, and Biological Evaluation of Dual-Target Inhibitors of Acetylcholinesterase (AChE) and Phosphodiesterase 9A (PDE9A) for the Treatment of Alzheimer’s Disease

Hu, J., Huang, Y.-D., Pan, T., Zhang, T., Su, T., Li, X., Luo, H., & Huang, L. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00376 · Cited by 33 · see citing works

Discovery of novel hybrids containing clioquinol−1-benzyl-1,2,3,6-tetrahydropyridine as multi-target-directed ligands (MTDLs) against Alzheimer's disease

Li, X., Li, T., Zhang, P., Li, X., Lu, L., Sun, Y., Zhang, B., Allen, S., White, L. J., Phillips, J. B., et al. (2022) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2022.114841 · Cited by 29 · see citing works

Design, synthesis and biological evaluation of novel copper-chelating acetylcholinesterase inhibitors with pyridine and N-benzylpiperidine fragments

Zhou, Y., Sun, W., Peng, J., Yan, H., Zhang, L., Liu, X., & Zuo, Z. (2019) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2019.103322 · Cited by 23 · see citing works

Synthesis and molecular dynamic simulation studies of novel N-(1-benzylpiperidin-4-yl) quinoline-4-carboxamides as potential acetylcholinesterase inhibitors

Pashaei, H., Rouhani, A., Nejabat, M., Hadizadeh, F., Mirzaei, S., Nadri, H., Maleki, M. F., & Ghodsi, R. (2021) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2021.130919 · Cited by 20 · see citing works

New Insights into the Development of Donepezil-Based Hybrid and Natural Molecules as Multi-Target Drug Agents for Alzheimer’s Disease Treatment

Angelova, V. T., Stoyanov, B. P., & Simeonova, R. (2024) · Molecules · doi:10.3390/molecules29225314 · Cited by 19 · see citing works

N ‐Benzyl piperidine Fragment in Drug Discovery

Sharma, A., Sharma, M., & Bharate, S. B. (2024) · ChemMedChem · doi:10.1002/cmdc.202400384 · Cited by 17 · see citing works

From Hybrids to New Scaffolds: The Latest Medicinal Chemistry Goals in Multi-target Directed Ligands for Alzheimers Disease

Alarcón‐Espósito, J., Mallea, M., & Rodríguez-Lavado, J. (2020) · Current Neuropharmacology · doi:10.2174/1570159x18666200914155951 · Cited by 18 · see citing works

Recent advances in the natural product analogues for the treatment of neurodegenerative diseases

Zhang, J., Jiang, P., Wang, S., Li, M., Hao, Z., Guan, W., Pan, J., Wu, J., Zhang, Y., Li, H. L., et al. (2024) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2024.107819 · Cited by 13 · see citing works

Curcuminoids and Novel Opportunities for the Treatment of Alzheimer's Disease: Which Molecules are Actually Effective?

Zholos, A. V., Moroz, O. F., & Storozhuk, M. (2018) · Current Molecular Pharmacology · doi:10.2174/1874467211666181012150847 · Cited by 12 · see citing works

The Hybrid Compounds as Multi-target Ligands for the Treatment of Alzheimer's Disease: Considerations on Donepezil

Gülcan, H. O., & Koşar, M. (2021) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026621666211111153626 · Cited by 12 · see citing works

Recent Progress in the Treatment Strategies for Alzheimer’s Disease

Kumar, V., & Roy, K. (2023) · Neuromethods · doi:10.1007/978-1-0716-3311-3_1 · Cited by 11 · see citing works

Donepezil and Memantine Derivatives for Dual-Function and Prodrug Applications in Alzheimer’s Disease

Terpstra, K., GUTIERREZ, C. G., Gui, K., & Mirica, L. M. (2025) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5c00493 · Cited by 11 · see citing works

Recent Modifications of Anti-dementia Agents Focusing on Tacrine and/or Donepezil Analogs

Mohamed, L. W., Mohamed, K. O., Sayed, H. S., & Mahmoud, Z. (2022) · Medicinal Chemistry · doi:10.2174/1573406418666220827155615 · Cited by 12 · see citing works

Design, Synthesis, Molecular Docking and Biological Evaluation of Donepezil Analogues as Effective Anti-Alzheimer Agents.

Alshamari, A. K., Elsawalhy, M., Alhajri, A., Hassan, A. A., Elharrif, M. G., Sam, G., Al-Amshany, Z. M., Alshehri, Z., Alshehri, F. F., & Hassan, N. A. (2023) · Egyptian Journal of Chemistry · doi:10.21608/ejchem.2023.231046.8475 · Cited by 9 · see citing works

Curcumin-Derived Heterocycles as Anticancer Agents. A Systematic Review.

Bahmani, A., Najafi, Z., & Chehardoli, G. (2022) · Organic Preparations and Procedures International · doi:10.1080/00304948.2022.2094659 · Cited by 9 · see citing works

Magnetic Levitational Assembly of Differentiated SH‐SY5Y Cells for Aβ‐Induced 3D Alzheimer's Disease Modeling and Curcumin Screening

Bilginer-Kartal, R., & Yıldız, A. A. (2025) · Macromolecular Bioscience · doi:10.1002/mabi.202400658 · Cited by 6 · see citing works

Curcumin Derivatives as Metal-Chelating Agents: Implications for Potential Therapeutic Agents for Neurological Disorders

Ferrari, É. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-815461-8.00015-3 · Cited by 5 · see citing works

Curcumin in Neurological Disorders: An Overview

Dhir, A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-815461-8.00004-9 · Cited by 3 · see citing works

A Recent Appraisal of Small-Organic Molecules as Anti-Alzheimer’s Agents

Gupta, M. L., Kumar, A., Ojha, M., Khan, S. K., & Nain, S. (2022) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557522666220922105934 · Cited by 3 · see citing works

A Novel Donepezil–Caffeic Acid Hybrid: Synthesis, Biological Evaluation, and Molecular Docking Studies

Kılıçaslan, D., Kurt, A. H., Köse, M., Çeşme, M., Güngör, Ö., Öztabağ, C. K., & Doğaner, A. (2023) · Biochemistry (Moscow) · doi:10.1134/s0006297923010054 · Cited by 2 · see citing works

Recent Advances in Computational Modeling of Multi-targeting Inhibitors as Anti-Alzheimer Agents

Thai, K., Tran, T., Tran, T., Cao, T., Ho, H. N., Huynh, P., Mai, T. T., Tran, T., Le, M.-T., & Tran, V.-T. (2023) · Neuromethods · doi:10.1007/978-1-0716-3311-3_8 · Cited by 2 · see citing works

First in class pyrrolo[2,3‐d]pyrimidine derivatives fused to fluorobenzylpiperidines as dual ligands of acetylcholinesterase and histamine H3 receptor

Añazco, T., Werner, T., Torres, M. J., Hornos‐Carneiro, M. F., Fernández, J., Živković, A., Salas, C. O., Castro‐Álvarez, A., Gutiérrez, M., Stark, H., et al. (2025) · Archiv der Pharmazie · doi:10.1002/ardp.202400387 · Cited by 2 · see citing works

Therapeutic Implication of Herbal Phytoconstituents in Alzheimer’s Disease

Rihal, V., Khan, H., Singh, T. G., & Grewal, A. K. (2021) · Journal of Pharmaceutical Technology Research and Management · doi:10.15415/jptrm.2021.92007 · Cited by 2 · see citing works

Nutraceuticals and Natural Product Derivatives in the Premises of Disease Prevention

Ullah, M. F., Bhat, S. H., & Abuduhier, F. M. (2018) · doi:10.1002/9781119436713.ch5 · Cited by 1 · see citing works

Multi-functional Ligands and Molecular Hybridization: Conceptual Aspects and Application in the Innovative Design of Drug Candidate Prototypes for Neurodegenerative Diseases

Silva, M. D. F., Viegas, F. P. D., Gontijo, V. S., Ortiz, C. J. C., Franco, G. D. R. R., Ernesto, J. T., Damásio, C. M., Fonseca, G. P. D. S., Silva, I. M. F., Massuda, L. E., et al. (2023) · Frontiers in clinical drug research. CNS and neurological disorders · doi:10.2174/9789815123319123110003

A novel donepezil-caffeic acid hybrid: synthesis, biological evaluation, and molecular docking studies

Kılıçaslan, D., Kurt, A. H., Köse, M., Çeşme, M., Güngör, Ö., Öztabağ, C. K., & Doğaner, A. (2023) · Biochemistry (Moscow) · doi:10.31857/s0320972523020033

Computer-aided drug design approach for alkaloids isolated from Stephania glandulifera Miers as potential acetylcholinesterase inhibitors

Dhungel, J., Shyaula, S. L., Faizan, M., Rathnayaka, R. K., & Agrawal, M. (2025) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2025.2474054

In vitro and in vivo evaluation of 1,4-bis-benzylpiperazine-2-carboxylic acid derivatives as potential multi-target directed ligands (MTDLs) anti-Alzheimer's agents

Soliman, A. M., El-wahab, H. A. A. A., Eissa, R. G., Baraka, N. M., & Omar, F. A. (2025) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2025.108750

Emerging Trends in Therapeutic Potential of Curcumin in Alzheimer’s Disease

Bashir, S., Khan, A. S., Gilani, A.-U.-H., & Ahmed, T. (2025) · Nutritional neurosciences · doi:10.1007/978-981-95-2736-6_6

Rational drug design for Alzheimer’s disease: from approved therapies to next-generation clinical candidates and AI-guided innovation

Saffour, S., Gül, T. S., & Gul, H. I. (2026) · Future Medicinal Chemistry · doi:10.1080/17568919.2026.2714022

Synergistic approaches to Alzheimer’s disease: exploring the combined efficacy of phytoconstituents and conventional drugs

Kumar, A. (2026) · Inflammopharmacology · doi:10.1007/s10787-026-02417-w

BindingDB Entry 50018793: Discovery of novel hybrids containing clioquinol-1-benzyl-1,2,3,6-tetrahydropyridine as multi-target-directed ligands (MTDLs) against Alzheimer's disease.

BindingDB (2024) · UC San Diego · doi:10.7270/q2sn0f6c

BindingDB Entry 50021243: Curcumin hybrid molecules for the treatment of Alzheimer's disease: Structure and pharmacological activities.

BindingDB (2025) · UC San Diego · doi:10.7270/q2g73kb1

BindingDB Entry 50007853: Dipropargyl substituted diphenylpyrimidines as dual inhibitors of monoamine oxidase and acetylcholinesterase.

BindingDB (2021) · UC San Diego · doi:10.7270/q2dv1p69

BindingDB Entry 50007842: Multi-target design strategies for the improved treatment of Alzheimer's disease.

BindingDB (2021) · UC San Diego · doi:10.7270/q2kh0rnp

Synthesis and evaluation of multi-target-directed ligands for the treatment of Alzheimer’s disease based on the fusion of donepezil and melatonin

Wang, J. Q., Wang, Z., Li, X., Li, F., Wu, J., Kong, L., & Wang, X. (2016) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2016.07.025 · Cited by 79 · see citing works

Synthesis and Evaluation of Multi-Target-Directed Ligands against Alzheimer’s Disease Based on the Fusion of Donepezil and Ebselen

Luo, Z., Sheng, J., Sun, Y., Lu, C., Yan, J., Liu, A., Luo, H., Huang, L., & Li, X. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm401047q · Cited by 178 · see citing works

Design, synthesis, and evaluation of chalcone-Vitamin E-donepezil hybrids as multi-target-directed ligands for the treatment of Alzheimer’s disease

Sang, Z., Song, Q., Cao, Z., Deng, Y., & Zhang, L. (2021) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2021.1993845 · Cited by 33 · see citing works

Donepezil-derived multi-target-directed ligands: design, synthesis, and anti-Alzheimer's evaluation

Bassiouny, M. S., Shahin, M. I., Jaballah, M. Y., Ahmed, T. E., Henary, M., & Samir, N. (2026) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2026.109924 · Cited by 3 · see citing works

Synthesis of donepezil-based multifunctional agents for the treatment of Alzheimer’s disease

Yerdelen, K. Ö., Koca, M., Anıl, B., Sevindik, H. G., Kasap, Z., Halıcı, Z., Turkaydin, K., & Gunesacar, G. (2015) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2015.10.051 · Cited by 24 · see citing works